AzTrials
AzTrials

Discal SciaticaPhase 3EPI-AMELIENCT02151045

Comparison of a Cortivazol (ALTIM®) Infiltration of Posterior Epidural Space at L3-L4 Stage Versus an Epidural Infiltration of Cortivazol (ALTIM®) on Contact With Disco Radicular Conflict in Discal Sciatica

A Phase 3 study testing Non target epidural infiltration done at L3-L4 stage and Epidural infiltration on contact of disco radicular conflict in people with Discal Sciatica, run by University Hospital, Montpellier at 2 sites in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In discal sciatica, after failure of medical treatment, the investigators propose frequently a spinal infiltration of corticoids the most closer of disco-radicular conflict. Recently, some cases of paraplegia during lumbar foraminal infiltrations have induce a reduction of indications of this type of infiltration. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Discal Sciatica
What is being tested?
Non target epidural infiltration done at L3-L4 stage and Epidural infiltration on contact of disco radicular conflict
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
112 participants
Where
2 sitesFrance
Study dates
Mar 2012to Mar 2017
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Informed consent
  • Aged from 18 to 65 years
  • Affiliated or benefit from an insurance regimen
  • Patient with a sciatic answering to the definition
  • Discal sciatica more than 15 days and less than 6 months
  • Discal hernia (scan or RMI)
  • Negative BHCG and normal coagulation parameters

Who cannot join

  • History of lumbar surgery
  • Spinal infiltration of corticoids in 30 days before inclusion
  • Iode allergy
  • Anticoagulation therapy, unbalanced type 2 diabetes, instable HTA
  • Motor loss < 4 (muscular testing)
  • Sphincter disorder (cauda equida syndrome)

Trial locations and contacts

2 sites in 1 country.

France2 sites, 2 recruiting
  • CHU de Montpellier - Hôpital Lapeyronie

    Montpellier, 34295

    Eric ET THOMAS, MD, +33 4 67 33 86 40, e-thomas@chu-montpellier.fr

    Eric ET THOMAS, MD

    Recruiting
  • CHU Carémeau

    Nîmes, 30000

    Cécile CG GAUJOUX-VIALA, MD, +33 4 66 68 31 20, cecilegaujouxviala@yahoo.fr

    Cécile CG GAUJOUX-VIALA, MD

    Recruiting

Other trials in France

About this study

Official title: Comparison of a Cortivazol (ALTIM®) Infiltration of Posterior Epidural Space at L3-L4 Stage Versus an Epidural Infiltration of Cortivazol (ALTIM®) on Contact With Disco Radicular Conflict in Discal Sciatica - Controlled Randomized Trial With Double Blind Evaluation

In discal sciatica, after failure of medical treatment, the investigators propose frequently a spinal infiltration of corticoids the most closer of disco-radicular conflict. Recently, some cases of paraplegia during lumbar foraminal infiltrations have induce a reduction of indications of this type of infiltration. An alternative would be to propose a lateral epidural infiltration on contact with conflict.The objective of this study is to compare, in 112 patients with a less than 6 months discal sciatica, the efficacy on pain of a non target posterior epidural space infiltration of corticoids done at L3-L4 stage on scan control versus an epidural infiltration of the same corticoid done in lateral on contact of disco radicular conflict on scan control.

Conditions
Discal Sciatica
Being tested
Non target epidural infiltration done at L3-L4 stage, Epidural infiltration on contact of disco radicular conflict
Keywords
Epidural infiltration of Corticoids, L3-L4 stage, On contact of disco radicular conflict, Scan control

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Non target epidural infiltration done at L3-L4 stageProcedure or surgery

    For patients included in control arm, a non target posterior epidural space infiltration of corticoids will be done at L3-L4 stage on scan control

  • Epidural infiltration on contact of disco radicular conflictProcedure or surgery

    For patients included in experimental arm, an epidural infiltration of corticoids will be done in lateral on contact of disco radicular conflict on scan control.

Study groups in NCT02151045
Study groupRoleWhat they receive
Non target epidural infiltration at L3-L4 stageActive comparatorIn this control arm, there are patients with a non target posterior epidural space infiltration of corticoids done at L3-L4 stage on scan control. These patients must have a discal hernia confirmed by scanner or RMI
Receives: Procedure: Non target epidural infiltration done at L3-L4 stage
Epidural infiltration on contact of disco radicular conflictExperimentalIn this experimental arm, there are patients with an epidural infiltration of corticoids done in lateral on contact of disco radicular conflict on scan control. These patients must have a discal hernia confirmed by scanner or RMI
Receives: Procedure: Epidural infiltration on contact of disco radicular conflict

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain evolution on analogic visual scale (EVA) ay Day 30

    Measured: at Day 30 after infiltration

Secondary outcomes (20)
  1. Pain evolution on analogic visual scal (EVA) at Day 7

    Measured: at day 7 after infiltration

  2. Pain evolution on analogic visual scal (EVA) at month 3

    Measured: at month 3 after infiltration

  3. Pain evolution on analogic visual scal (EVA) at month 6

    Measured: at month 6 after infiltration

  4. Pain evolution on analogic visual scal (EVA) at month 12

    Measured: at month 12 after infiltration

  5. drug consumption at day 7

    Measured: at day 7 after infiltration

  6. drug consumption at month 3

    Measured: at month 3 after infiltration

  7. drug consumption at month 6

    Measured: at month 6 after infiltration

  8. drug consumption at month 12

    Measured: at month 12 after infiltration

  9. functional handicap at Day 7

    functional handicap is assessed by auto-questionnary

    Measured: at day 7 after infiltration

  10. functional handicap at month 3

    functional handicap is assessed by auto-questionnary

    Measured: at month 3 after infiltration

  11. functional handicap at month 6

    functional handicap is assessed by auto-questionnary

    Measured: at month 6 after infiltration

  12. functional handicap at month 12

    functional handicap is assessed by auto-questionnary

    Measured: at month 12 after infiltration

  13. professional activity recovery at Day 7

    professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why?

    Measured: at day 7 after infiltration

  14. professional activity recovery at month 3

    professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why?

    Measured: at month 3 after infiltration

  15. professional activity recovery at month 6

    professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why?

    Measured: at month 6 after infiltration

  16. professional activity recovery at month 12

    professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why?

    Measured: at month 12 after infiltration

  17. new epidural infiltration or surgery of discal hernia at Day 7

    Measured: at day 7 after infiltration

  18. new epidural infiltration or surgery of discal hernia at month 3

    Measured: at month 3 after infiltration

  19. new epidural infiltration or surgery of discal hernia at month 6

    Measured: at month 6 after infiltration

  20. new epidural infiltration or surgery of discal hernia at month 12

    Measured: at month 12 after infiltration

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 May 2014 (estimated)
  2. Study startMar 2012
  3. Primary completionMar 2017 (estimated)
  4. Study completionMar 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
112 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02151045
Sponsor's protocol ID
8708
Acronym
EPI-AMELIE
Status last verified
Aug 2015
First submitted
28 May 2014
Last updated
1 Sep 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Non target epidural infiltration done at L3-L4 stage and Epidural infiltration on contact of disco radicular conflict in people with Discal Sciatica, run by University Hospital, Montpellier at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Sep 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Eric ET THOMAS, MD (+33 4 67 33 86 40, e-thomas@chu-montpellier.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain evolution on analogic visual scale (EVA) ay Day 30 (time frame: at Day 30 after infiltration). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in